Ongoing clinical trials of the pleiotropic effects of statins

by Jean Davignon, Lawrence A Leiter
Published 2005-04-01

Effectiveness of gliclazide MR 60 mg in the management of type 2 diabetes: analyses from the EASYDia trial

by Lawrence A. Leiter, Marina V. Shestakova, Ilhan Satman
Published 2018-04-01

Achieving postprandial glucose control with lixisenatide improves glycemic control in patients with type 2 diabetes on basal insulin: a post-hoc analysis of pooled data

by Jaime A. Davidson, William Stager, Sachin Paranjape, Rachele Berria, Lawrence A. Leiter
Published 2020-01-01

Use of non‐LDL‐C lipid‐lowering medications in patients with type 2 diabetes

by Suzanne V. Arnold, Kensey Gosch, Nathan D. Wong, Vittal Hejjaji, Abhinav Goyal, Lawrence A. Leiter, Mikhail Kosiborod
Published 2020-07-01

From glucose lowering agents to disease/diabetes modifying drugs: a “SIMPLE” approach for the treatment of type 2 diabetes

by Ofri Mosenzon, Stefano Del Prato, Meir Schechter, Lawrence A. Leiter, Antonio Ceriello, Ralph A. DeFronzo, Itamar Raz
Published 2021-04-01

Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial

by Lawrence A. Leiter, Stephen C. Bain, Irene Hramiak, Esteban Jódar, Sten Madsbad, Theis Gondolf, Thomas Hansen, Ingrid Holst, Ildiko Lingvay
Published 2019-06-01

The Effect of Small Doses of Fructose and Its Epimers on Glycemic Control: A Systematic Review and Meta-Analysis of Controlled Feeding Trials

by Jarvis C. Noronha, Catherine R. Braunstein, Sonia Blanco Mejia, Tauseef A. Khan, Cyril W. C. Kendall, Thomas M. S. Wolever, Lawrence A. Leiter, John L. Sievenpiper
Published 2018-11-01

Time to cardiovascular benefits of empagliflozin: a post hoc observation from the EMPA‐REG OUTCOME trial

by Subodh Verma, Lawrence A. Leiter, Bernard Zinman, Abhinav Sharma, Michaela Mattheus, David Fitchett, Jyothis George, Anne Pernille Ofstad, Mikhail N. Kosiborod, Christoph Wanner, Silvio E. Inzucchi
Published 2021-08-01

Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol

by Helen M. Colhoun, Lawrence A. Leiter, Dirk Müller-Wieland, Bertrand Cariou, Kausik K. Ray, Francisco J. Tinahones, Catherine Domenger, Alexia Letierce, Marc Israel, Rita Samuel, Stefano Del Prato
Published 2020-02-01

Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies

by Kausik K. Ray, Stefano Del Prato, Dirk Müller-Wieland, Bertrand Cariou, Helen M. Colhoun, Francisco J. Tinahones, Catherine Domenger, Alexia Letierce, Jonas Mandel, Rita Samuel, Maja Bujas-Bobanovic, Lawrence A. Leiter
Published 2019-11-01

Design and rationale of the ODYSSEY DM-DYSLIPIDEMIA trial: lipid-lowering efficacy and safety of alirocumab in individuals with type 2 diabetes and mixed dyslipidaemia at high card...

by Dirk Müller-Wieland, Lawrence A. Leiter, Bertrand Cariou, Alexia Letierce, Helen M. Colhoun, Stefano Del Prato, Robert R. Henry, Francisco J. Tinahones, Lisa Aurand, Jaman Maroni, Kausik K. Ray, Maja Bujas-Bobanovic
Published 2017-05-01

Does empagliflozin modulate the autonomic nervous system among individuals with type 2 diabetes and coronary artery disease? The EMPA-HEART CardioLink-6 Holter analysis

by Vinay Garg, Subodh Verma, Kim A. Connelly, Andrew T. Yan, Aditya Sikand, Ankit Garg, Paul Dorian, Fei Zuo, Lawrence A. Leiter, Bernard Zinman, Peter Jüni, Atul Verma, Hwee Teoh, Adrian Quan, C. David Mazer, Andrew C.T. Ha
Published 2020-09-01

Effect of tree nuts on glycemic control in diabetes: a systematic review and meta-analysis of randomized controlled dietary trials.

by Effie Viguiliouk, Cyril W C Kendall, Sonia Blanco Mejia, Adrian I Cozma, Vanessa Ha, Arash Mirrahimi, Viranda H Jayalath, Livia S A Augustin, Laura Chiavaroli, Lawrence A Leiter, Russell J de Souza, David J A Jenkins, John L Sievenpiper
Published 2014-01-01

Update to Evidence-Based Secondary Prevention Strategies After Acute Coronary Syndrome

by David H. Fitchett, MD, Lawrence A. Leiter, MD, Peter Lin, MD, Jennifer Pickering, BScPhm, Robert Welsh, MD, James Stone, PhD, MD, Jean Gregoire, MD, Philip McFarlane, PhD, MD, Anatoly Langer, MD, Anil Gupta, MD, Shaun G. Goodman, MD, MSc
Published 2020-09-01

Effect of Replacing Animal Protein with Plant Protein on Glycemic Control in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

by Effie Viguiliouk, Sarah E. Stewart, Viranda H. Jayalath, Alena Praneet Ng, Arash Mirrahimi, Russell J. de Souza, Anthony J. Hanley, Richard P. Bazinet, Sonia Blanco Mejia, Lawrence A. Leiter, Robert G. Josse, Cyril W.C. Kendall, David J.A. Jenkins, John L. Sievenpiper
Published 2015-12-01

GOAL Canada: Physician Education and Support Can Improve Patient Management

by Anatoly Langer, MD, MSc, FRCP, Mary Tan, MSc, CCRP, Shaun G. Goodman, MD, MSc, FRCP, Jean Grégoire, MD, FRCP, Peter J. Lin, MD, CCFP, G. B. John Mancini, MD, FRCP, James A. Stone, MD, PhD, FRCP, Cheryll Wills, CCRP, Caroline Spindler, CCRP, Lawrence A. Leiter, MD, FRCP
Published 2020-03-01

A randomized trial of icosapent ethyl in ambulatory patients with COVID-19

by Andrew Kosmopoulos, Deepak L. Bhatt, Gus Meglis, Raj Verma, Yi Pan, Adrian Quan, Hwee Teoh, Maya Verma, Lixia Jiao, Robert Wang, Rebecca A. Juliano, Mahesh Kajil, Mikhail N. Kosiborod, Basel Bari, Abdullahi A. Berih, Mallory Aguilar, Antonnette Escano, Andrew Leung, Idelta Coelho, Makoto Hibino, Rafael Díaz, R. Preston Mason, Ph. Gabriel Steg, Tabassome Simon, Alan S. Go, Andrew P. Ambrosy, Richard Choi, Arthur M. Kushner, Lawrence A. Leiter, Mohammed Al-Omran, Subodh Verma, C. David Mazer
Published 2021-09-01